Cancer Risk after Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy

BACKGROUND AND OBJECTIVES: Cyclophosphamide treatment improves renal survival in patients with idiopathic membranous nephropathy. However, use of cyclophosphamide is associated with cancer. The incidence of malignancies in patients with idiopathic membranous nephropathy was evaluated, and the cancer...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: van den Brand, Jan A.J.G., van Dijk, Peter R., Hofstra, Julia M., Wetzels, Jack F.M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2014
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4046727/
https://ncbi.nlm.nih.gov/pubmed/24855280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.08880813
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak